Largest Ever Trial in Parkinson`s Disease Shows That For Long Term Treatment Levodopa is Better Than Newer Drugs

Share

(June 11, 2014) - For long-term treatment of newly diagnosed Parkinson's disease (PD), the old drug levodopa provides better mobility and a higher quality of life than the two main alternatives, dopamine agonists (DA) and monoamine oxidase type B inhibitors (MAOBI), according to the largest-ever trial of PD treatment (PD MED), published in The Lancet. Read more…

Click for a printer friendly version

Back to top